A detailed history of New Edge Advisors, LLC transactions in Icad Inc stock. As of the latest transaction made, New Edge Advisors, LLC holds 138,194 shares of ICAD stock, worth $272,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138,194
Previous 148,618 7.01%
Holding current value
$272,242
Previous $193,000 11.92%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.19 - $1.74 $12,404 - $18,137
-10,424 Reduced 7.01%
138,194 $216,000
Q2 2024

Aug 15, 2024

SELL
$1.28 - $1.9 $12,508 - $18,566
-9,772 Reduced 6.17%
148,618 $193,000
Q1 2024

May 14, 2024

SELL
$1.35 - $2.27 $5,860 - $9,854
-4,341 Reduced 2.67%
158,390 $255,000
Q4 2023

Feb 13, 2024

SELL
$1.27 - $2.06 $7,782 - $12,623
-6,128 Reduced 3.63%
162,731 $288,000
Q3 2023

Nov 14, 2023

SELL
$1.8 - $3.61 $2,971 - $5,960
-1,651 Reduced 0.97%
168,859 $356,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.63 $1,003 - $1,434
-880 Reduced 0.51%
170,510 $277,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.84 $2,893 - $6,847
-2,411 Reduced 1.39%
171,390 $212,000
Q4 2022

Feb 14, 2023

SELL
$1.6 - $2.37 $740 - $1,097
-463 Reduced 0.27%
173,801 $318,000
Q3 2022

Nov 14, 2022

BUY
$2.04 - $4.32 $6,793 - $14,385
3,330 Added 1.95%
174,264 $366,000
Q2 2022

Aug 09, 2022

SELL
$3.02 - $4.56 $3,300 - $4,984
-1,093 Reduced 0.64%
170,934 $684,000
Q1 2022

May 13, 2022

BUY
$3.92 - $7.48 $72,367 - $138,088
18,461 Added 12.02%
172,027 $767,000
Q4 2021

Feb 17, 2022

SELL
$6.7 - $11.38 $24,843 - $42,197
-3,708 Reduced 2.36%
153,566 $1.11 Million
Q3 2021

Oct 29, 2021

BUY
$10.11 - $17.56 $384,543 - $667,912
38,036 Added 31.9%
157,274 $1.69 Million
Q2 2021

Jul 22, 2021

BUY
$14.9 - $20.82 $1.78 Million - $2.48 Million
119,238 New
119,238 $2.06 Million

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $49.9M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.